(Q43276340)

English

The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and β-cell dysfunction in overweight and obese nondiabetic men.

scientific article published on 15 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and β-cell dysfunction in overweight and obese nondiabetic men. (English)

1 reference

Europe PubMed Central

18 November 2017

0 references

0 references

insulin resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Adria Giacca

1 reference

Europe PubMed Central

18 November 2017

1

object named as

Changting Xiao

1 reference

Europe PubMed Central

18 November 2017

author name string

Gary F Lewis

3

1 reference

Europe PubMed Central

18 November 2017

publication date

15 September 2009

1 reference

Europe PubMed Central

18 November 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

18 November 2017

297

1 reference

Europe PubMed Central

18 November 2017

5

1 reference

Europe PubMed Central

18 November 2017

E1205-11

1 reference

Europe PubMed Central

18 November 2017

Accurate assessment of beta-cell function: the hyperbolic correction

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Mechanisms of fatty acid-induced inhibition of glucose uptake

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Salicylates increase insulin secretion in healthy obese subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Salsalate improves glycemia and inflammatory parameters in obese young adults

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Acetylsalicylic Acid Restores Acute Insulin Response Reduced by Furosemide in Man

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Fatty acids and insulin secretion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Prevention of fat-induced insulin resistance by salicylate

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Assessment of insulin secretion in relation to insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Aspirin Causes Tissue Insensitivity to Insulin In Normal Man*

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Effects of Salicylate, Tolbutamide, and Prostaglandin E2 on Insulin Responses to Glucose in Noninsulin- Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00313.2009

21 January 2018

Identifiers

10.1152/AJPENDO.00313.2009

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43276340&oldid=2098070643"